AVROBIO, Inc. – Trademark Portfolio
Entity Type: 03
AVROBIO, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PLATO and AVROBIO. The owner is based in Cambridge, MA.
Building 300, Suite 201
One Kendall Square
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
AVROBIO, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does AVROBIO, Inc. have?
AVROBIO, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does AVROBIO, Inc. file in?
AVROBIO, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AVROBIO, Inc.'s most well-known trademarks?
AVROBIO, Inc.'s registered trademark portfolio includes well-known marks such as PLATO and AVROBIO. These are among 2 currently registered trademarks in the portfolio.
What is AVROBIO, Inc.'s trademark registration success rate?
AVROBIO, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.